Finance

Lists
Why is ADPT up ၃.၅၈%?
Dive Deeper
ADPT:NASDAQ
Adaptive Biotechnologies Corp
၂၈.၃၅ US$
+၃.၅၈%
(+၀.၉၈) 1D
၂၈.၃၅ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၂, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADPT...
Open
၂၇.၅၉ US$
High
၂၈.၄၁ US$
Low
၂၇.၃၁ US$
Mkt. cap
၄၅၂.၄၅ ဋေ
Avg. vol.
၂.၂၃ သန်း
Volume
၁.၅၈ သန်း
52-wk high
၂၉.၉၆ US$
52-wk low
၁၂.၀၀ US$
EPS
-၀.၄၁ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၉၆ ကုဋေ
No. of employees
၆၂၄
Open
၂၇.၅၉ US$
High
၂၈.၄၁ US$
Low
၂၇.၃၁ US$
Mkt. cap
၄၅၂.၄၅ ဋေ
Avg. vol.
၂.၂၃ သန်း
Volume
၁.၅၈ သန်း
52-wk high
၂၉.၉၆ US$
52-wk low
၁၂.၀၀ US$
EPS
-၀.၄၁ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၉၆ ကုဋေ
No. of employees
၆၂၄
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၈ မိနစ်
3 Growth Stocks For October 2026
Benzinga
Benzinga
·
ပြီးခဲ့သည့် ၁ နာရီ
S&P 500 Index Outlook: Top Catalysts for US Stocks This Week
About Adaptive Biotechnologies Corp
CEOChad Robins
Employees၆၂၄
Founded၂၀၀၉
Headquartersဆီအက်တယ်, ဝါရှင်တန်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to ADPT in the past 3 months
Strong buy
Buy
8
Hold
1
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for ADPT in the last 3 months.
Highest
Current ၂၈.၃၅ US$
၃၅.၀၀ US$ (+၂၃.၄၆%)
Average
၂၉.၃၆ US$ (+၃.၅၆%)
Lowest
၂၂.၀၀ US$ (-၂၂.၄၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Subbu Nambi
Guggenheim
Buy
Maintained
၃၂.၀၀ US$
+၁၂.၉%
10/01/2026
Evie Koslosky
Goldman Sachs
Buy
Initiated
၃၅.၀၀ US$
+၂၃.၅%
09/29/2026
Mark Massaro
BTIG
Buy
Reiterated
၃၄.၀၀ US$
+၁၉.၉%
09/22/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
09/17/2026
David Westenberg
Piper Sandler
Buy
Maintained
၂၇.၅၀ US$
-၃%
08/24/2026
Sebastian Sandler
J.P. Morgan
Buy
Maintained
၂၇.၀၀ US$
-၄.၈%
07/30/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Maintained
၂၂.၀၀ US$
-၂၂.၄%
07/30/2026
Matt Larew
William Blair
Buy
Maintained
-
-
07/30/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
၂၈.၀၀ US$
-၁.၂%
07/30/2026
Andrew Brackmann
William Blair
Buy
Reiterated
-
-
06/16/2026
Last report
၂၀၂၆ ဇူ ၂၉
Fiscal period
Q2 2026
EPS / Est. (USD)
-၀.၂၅ US$ / -၀.၁၃ US$
-၈၇.၂၀%miss
Revenue / Est. (USD)
၇.၁၆ ကုဋေ / ၆.၅၄ ကုဋေ
+၉.၃၂%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၉.၄၀ ကုဋေ
၇.၁၇ ကုဋေ
၇.၀၉ ကုဋေ
၇.၁၆ ကုဋေ
Cost of goods sold
၄.၁၈ ကုဋေ
၄.၀၀ ကုဋေ
၄.၂၃ ကုဋေ
၃.၉၃ ကုဋေ
Cost of revenue
၄.၁၈ ကုဋေ
၄.၀၀ ကုဋေ
၄.၂၃ ကုဋေ
၃.၉၃ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၁၄ ကုဋေ
၄.၄၀ ကုဋေ
၄.၇၃ ကုဋေ
၄.၇၆ ကုဋေ
Operating expense
၄.၁၉ ကုဋေ
၄.၄၅ ကုဋေ
၄.၇၇ ကုဋေ
၄.၈၀ ကုဋေ
Total operating expenses
၈.၃၇ ကုဋေ
၈.၄၅ ကုဋေ
၉.၀၁ ကုဋေ
၈.၇၃ ကုဋေ
Operating income
၁.၀၃ ကုဋေ
-၁.၂၈ ကုဋေ
-၁.၉၂ ကုဋေ
-၁.၅၈ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
၉.၅၄ သန်း
-၁.၃၆ ကုဋေ
-၂.၀၀ ကုဋေ
-၃.၉၉ ကုဋေ
EBT excluding unusual items
၉.၅၄ သန်း
-၁.၃၉ ကုဋေ
-၂.၀၂ ကုဋေ
-၁.၆၂ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
၉.၅၅ သန်း
-၁.၃၆ ကုဋေ
-၂.၀၀ ကုဋေ
-၃.၉၈ ကုဋေ
Net profit margin
၁၀.၁၆%
-၁၈.၉၄%
-၂၈.၂၇%
-၅၅.၆၁%
Earnings per share
၀.၀၆
-၀.၀၉
-၀.၁၃
-၀.၂၅
Interest and investment income
၂.၂၃ သန်း
၁.၈၆ သန်း
၁.၉၄ သန်း
၂.၂၆ သန်း
Interest expense
-၂.၉၇ သန်း
-၂.၉၅ သန်း
-၂.၈၉ သန်း
-၂.၆၉ သန်း
Net interest expenses
-၇.၄၅ သိန်း
-၁.၀၉ သန်း
-၉.၄၅ သိန်း
-၄.၃၈ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၁.၄၇ ကုဋေ
-၈.၅၈ သန်း
-၁.၅၄ ကုဋေ
-၁.၂၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ